SCHEMBL2235842

SCHEMBL2235842

CCCC/C(=C\C(=O)O)c1cc(C)c(Oc2ccc(OCc3ccccc3F)cn2)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.37
MAOB P27338 2/20 0.37
ALKBH1 Q13686 1/20 0.35
PARP15 Q460N3 2/20 0.35
PARP10 Q53GL7 2/20 0.35
PARP14 Q460N5 1/20 0.35
PPARG P37231 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
GCK P35557 1/20 0.34
PTPN1 P18031 2/20 0.34
KCNH2 Q12809 1/20 0.34
SCN3A Q9NY46 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
PTGES O14684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231831 0.85 KMT2A (0.41) MAOBALKBH1MEN1KMT2AGCK
SCHEMBL2231791 0.84 PPARG (0.40) ALKBH1PPARGPTGESALOX5PSEN1
SCHEMBL2235847 0.84 ALOX5 (0.41) PPARGPOLBMAPTMAPK1PTGES
SCHEMBL2232578 0.83 PDPK1 (0.34) MEN1KMT2APOLB
SCHEMBL13582347 0.80 PTPN1 (0.43) MAOBMEN1KMT2APTPN1POLB
SCHEMBL13582345 0.80 PTPN1 (0.43) MAOBMEN1KMT2APTPN1POLB
SCHEMBL13582548 0.79 MAOB (0.45) MAOBALKBH1MEN1KMT2AGCK
SCHEMBL13582543 0.79 MAOB (0.45) MAOBALKBH1MEN1KMT2AGCK
SCHEMBL13582546 0.79 MAOB (0.45) MAOBALKBH1MEN1KMT2AGCK
SCHEMBL2235837 0.78 ALOX5 (0.42) TDP1MAOBMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed